Transforming growth factor β (TGFβ) family members signal via heterotetrameric complexes of type I (TβRI) and type II (TβRII) dual specificity kinase receptors. The availability of the receptors on the cell surface is controlled by several mechanisms. Newly synthesized TβRI and TβRII are delivered from the Golgi apparatus to the cell surface via separate routes. On the cell surface, TGFβ receptors are distributed between different microdomains of the plasma membrane and can be internalized via clathrin-and caveolae-mediated endocytic mechanisms. Although receptor endocytosis is not essential for TGFβ signaling, localization of the activated receptor complexes on the early endosomes promotes TGFβ-induced Smad activation. Caveolae-mediated endocytosis, which is widely regarded as a mechanism that facilitates the degradation of TGFβ receptors, has been shown to be required for TGFβ signaling via non-Smad pathways. The importance of proper control of TGFβ receptor intracellular trafficking is emphasized by clinical data, as mislocalization of receptors has been described in connection with several human diseases. Thus, control of intracellular trafficking of the TGFβ receptors together with the regulation of their expression, posttranslational modifications and down-regulation, ensure proper regulation of TGFβ signaling.
Introduction
Transforming growth factor β (TGFβ) belongs to a family consisting of more than 30 structurally related members [1, 2] . In addition to TGFβs, this family includes the bone morphogenetic proteins (BMPs), growth and differentiation factors (GDFs), activins, nodal, and Müllerian inhibiting substance; all members are dimeric molecules that play key roles in controlling developmental processes and tissue homeostasis in adults. At the cellular level, TGFβ family members regulate cell growth, differentiation, adhesion, migration and death, in a context-dependent and cell type-specific manner [3] . Deregulation of their signaling has been associated with various diseases, e.g. autoimmune disorders, cardiovascular diseases, and cancer [4, 5] .
TGFβ receptors bind TGFβ isoforms and transmit signals into the cell through activation of Smad-and non-Smad signaling pathways [4] . The cell surface heterotetrameric receptor complex is composed of two type II (TβRII) [5] and two type I (TβRI) [6] TGFβ receptors. TβRI and TβRII are both dual specificity kinases, and are characterized by strong serine/threonine, but weaker tyrosine, phosphorylation capacities [7] . The type III TGFβ receptor (TβRIII), a proteoglycan also known as β-glycan, functions mostly as a co-receptor which presents the ligand for signaling receptors [8] . However, recently it was shown that TβRIII, in addition, can participate in the regulation of intracellular trafficking of TβRI and TβRII [9] .
Unlike many other receptor types, most TGFβ receptors reside intracellularly; in response to certain stimuli, receptors are translocated to the plasma membrane, increasing cells' responsiveness to TGFβ stimulation [10] . Here, we review the trafficking of TGFβ receptors, including the regulation of their transport to plasma membrane, endocytosis, recycling, and degradation.
Trafficking of Newly Synthesized Receptors
TGFβ receptors are synthesized in the endoplasmic reticulum (ER) and undergo further modifications in the Golgi apparatus before being transported to the cell surface [11, 12] (Fig. 1) . Biosynthesis and processing of endogenous TβRI and TβRII have been studied in detail in TGFβ-responsive mink lung epithelial cells. Different rates and efficiencies of Golgi processing of newly synthesized native type I and type II receptors were observed, that could provide a potential mechanism for modulation of cellular responses to TGFβ [11, 12] .
In mink lung epithelial cells, TβRII is first synthesized as ã 60 kDa endoglycosidase H-sensitive precursor protein, which is converted to a mature~70 kDa protein [11] . Newly synthesized TβRII molecules have a half-life of~30 min in ER and most of them (~90%) are transported to the Golgi apparatus [12] . The Golgiprocessed forms of TβRII have a relatively short metabolic half-life, about 1-2.5 h [11, 12] .
TβRI is also first synthesized as a precursor form of molecular mass~53 kDa that is processed to a mature~55 kDa protein [11] . In contrast to TβRII, the endoglycosidase H-sensitive, ER form of the type I receptor has a half-life of 2.8-3 h, five to six times longer than the type II receptor [12] . The longer persistence of the type I receptor precursor form indicates a less efficient ER processing compared with that of the TβRII precursor [11] ; less than 50% of the newly made TβRI is converted to an endoglycosidase H-resistant form [12] . Such inefficient folding and processing of the TβRI in the ER could serve as a mechanism for controlling the number of plasma membrane receptors [12] .
Little is known about trafficking of the newly synthesized TGFβ receptors from the trans-Golgi network (TGN) to the cell surface. The intracellular transport of newly synthesized GFP-tagged TβRII was visualized by using fluorescence imaging in living MCF7 cells [13] . At 3 h after transfection, TβRII-GFP formed a cloud-like pattern near the nucleus. Tubulovesicular structures containing TβRII-GFP appeared 1 h later. Six hours after transfection, more fluorescent vesicles were clearly seen in pericentriolar area of the cytoplasm. The vesicle number reached a maximum at~8 h after transfection and remained nearly constant for at least 24 h [13] . Colocalization analysis indicated that the TβRII-containing vesicles formed from 3 to 8 h after transfection were mostly post-Golgi vesicles as they displayed low colocalization with the early endosome (EE) marker early endosomal antigen-1 (EEA1) and the recycling endosome marker Rab11, but high colocalization with Golgi markers [13] . At 24 h after transfection, the colocalization of TβRII-containing vesicles with the EE marker Rab5 and the recycling endosome marker Rab11 both increased significantly [13] , indicating that newly synthesized TβRII was endocytosed and entered a recycling trafficking route to the plasma membrane. Unlike TβRII, TβRI showed dispersed distribution under the same imaging conditions [13] . This is probably due to the much slower processing of the newly made TβRI in ER and Golgi [11, 12] .
The transportation of TβRII-containing vesicles is mediated by microtubules. Single-particle tracking showed that these vesicles traveled along the microtubules at an average speed of 0.51 μm/s [13] . The vesicle transportation was sensitive to the temperature and treatment with nocodazole, but was not affected by cytochalasin-D, an inhibitor of actin filament polymerization [13] .
Several factors were found to be able to influence the formation of TβRII-containing vesicles. The inhibition of TβRII autophosphorylation, defective N-linked glycosylation, and the presence of excessive extracellular K + all prohibited the formation of TβRII-containing vesicles [13] .
Distribution of TGFβ Receptors in the Plasma Membrane
Once exposed on the cell surface, TGFβ receptors can bind their ligands and form signaling complexes, activating both Smadmediated and non-Smad pathways (Fig. 2) . It has been shown that the distribution of the receptors in the plasma membrane is tightly regulated. In polarized epithelial cell cultures, TGFβ receptors localize to and signal from the basolateral plasma membrane; TGFβ applied from the apical side of the cell layer gives no response [14] [15] [16] [17] . Amino acid residues 529-538 (LTAxxVAxxF) in TβRII and residues 158-163 (VxxEED) in TβRI are required for basolateral expression [15, 17] . TβRIII is also targeted to the basolateral part of polarized mammary epithelial cells, and mutation of Pro826 in the short In the non-raft clathrin-coated pits activated TGFβ receptors bind and phosphorylate Smad2/3 initiating thereby Smad-mediated signaling. In the lipid raft/caveolin-1 positive compartment of the plasma membrane the receptors preferentially associate with Smad7, which negatively regulates Smad-mediated signaling by competing with Smad2/3 for interaction with TGFβ receptor type I (TβRI). On the other hand, Smad7 functions as an adaptor protein, facilitating the activation of non-Smad signaling pathways. Smad7 also recruits the E3 ubiquitin-protein ligases, Smurf1 and Smurf2, which direct ubiquitin-dependent degradation of the TGFβ receptor complex. Distribution of the receptors in the plasma membrane microdomains is dynamic and regulated by several mechanisms. In early endosomes (EE) Smad-mediated signaling is further enhanced by the FYVE domain-containing proteins SARA and endofin. It is not known whether non-Smad TGFβ signaling continues in the EE. Also, there are no data whether TGFβ receptors are redistributed between different subdomains of EE. In the nucleus, intracellular domain of TβRI (TβRI-ICD) directly regulates gene expression acting as a transcription factor.
cytoplasmic domain caused mislocalization of this receptor [18] . In non-epithelial or not polarized epithelial cells, TGFβ receptors are distributed more randomly, though immunofluorescence staining revealed high concentration of the receptors in membrane ruffles and in the leading edge of migrating cells [19, 20] ; however, it is not clear whether these receptors were exposed on the cell surface. It would be interesting to investigate if front-rear polarization of the cells affects the distribution of the TGFβ receptors in the plasma membrane similar to the apical-basolateral one. In addition, TGFβ receptors are partitioned also between microdomains of the plasma membrane, particularly they were found in non-raft clathrin-coated pits and caveolin-1 positive cholesterol-rich lipid rafts [21] . The different localizations may confer different signaling capabilities of TGFβ receptors. The receptors are distributed in a dynamic process which is regulated via changes in the chemical composition of the plasma membrane, expression of auxiliary proteins, extracellular stimuli, or by posttranslational modifications of the receptors themselves [4, 7, 22] (Fig. 1) . For example, stimulation of human renal proximal tubular epithelial cells with IL-6 resulted in an increased recruitment of TGFβ receptors to the non-lipid raft fraction and augmented TGFβ Smad signaling [23] , while treatment of these cells with exogenous hyaluronan shifted TGFβ receptors into caveolin-1 lipid raft-associated pools in an extracellular signalregulated kinase 1/2 (ERK1/2)-dependent manner [24] . Disintegrin and metalloproteinase domain-containing protein 12 (ADAM12) associates with TβRII and promotes receptor internalization via clathrin-coated pits through a mechanism independent of its protease activity [25] . The SH2 domain adaptor protein Dab2 restricts the lateral diffusion of TβRI in the plasma membrane and enhances its association with clathrin [26] . Casitas B-lineage lymphoma (c-Cbl), a known proto-oncogene encoding a ubiquitin E3 ligase, promotes TGFβ signaling by conjugating neural precursor cell-expressed, developmentally downregulated 8 (NEDD8), a ubiquitin-like protein, to TβRII at Lys556 and Lys567 [27] . Neddylation of TβRII promotes its endocytosis through clathrin-positive pits, while preventing its endocytosis via caveolae [27] . It has been suggested that the localization of the receptors in the plasma membrane specifies the composition of the receptor signaling complexes, intracellular routing of the receptors, and the resulting cellular responses [4, 7, 22] .
Clathrin-coated pits are small areas of the plasma membrane that are covered at the cytoplasmic surface with clathrin triskelions [28] . It has been suggested that both TβRI and TβRII are recruited to clathrin-coated pits through di-leucine-based motifs [29] . In the cytoplasmic region proximal to the transmembrane domain, the sequence Ile218-Ile219-Leu220 is necessary for TβRII endocytosis [30] , and TβRI is targeted for constitutive clathrin-mediated endocytosis via the Leu180-Ile181 motif [31] .
Caveolae are flask-shaped plasma membrane invaginations marked by the presence of caveolin-1 [32, 33] . In human umbilicalvein endothelial cells localization of both TGFβ receptors to the caveolin-1 positive lipid rafts was demonstrated using density gradient fractionation and co-immunoprecipitation [34] . While TβRI directly binds to the scaffolding domain of caveolin-1 [35] , partitioning of TβRII into caveolin-1 positive membrane rafts and domains is mediated via its extracellular domain [36] . An association between endogenous TβRI and caveolin-1 occurs rapidly after ligand activation and suppresses TGFβ-mediated phosphorylation of Smad2, possibly by inhibition of TβRI kinase activity [35] . Protein that interacts with C kinase 1 (PICK1) directly binds to the C-terminus of TβRI via its PDZ domain and acts as a scaffold protein to enhance the interaction between TβRI and caveolin-1, that leads to enhanced lipid raft/caveolae localization [37] . Increased concentration of cholesterol shifts the localization of TGFβ receptors from non-raft to lipid raft microdomains in the plasma membrane [38] . The GPIanchored protein CD109, a TGFβ co-receptor and a negative regulator of TGFβ signaling, associates with caveolin-1 and promotes localization of the TGFβ receptors into the caveolar compartment in the presence of ligand [39] . The adaptor protein p52ShcA competes with Smad3 for binding to TβRI and stabilizes the association of the receptor with caveolin-1 [40] .
It has been proposed that localization of TGFβ receptors to caveolae promotes formation of protein complexes that direct down-regulation of TGFβ signaling [21] (Fig. 2) . Thus, Smad7, which negatively regulates TGFβ signaling by competing with Smad2/3 for interaction with TβRI [41] [42] [43] , preferentially associates with the receptor in the raft compartment [21] . It also recruits the E3 ubiquitinprotein ligases, Smurf1 and Smurf2, which direct ubiquitin-dependent degradation of the TGFβ receptor complex [44, 45] . However, there are reports that demonstrate that lipid rafts are required for TGFβ signaling via non-Smad pathways (Fig. 2) . Thus, the localization of TGFβ receptors in caveolae is important for TGFβ-induced activation of ERK1/2 and p38 mitogen-activated protein kinase (MAPK) in human keratinocyte HaCaT cells [46] . Silencing of caveolin-1 expression in primary hepatocytes results in repression of TGFβ-induced Akt activation [47] . The adaptor protein p52ShcA facilitates TGFβ-induced Erk MAPK and Akt activation in epithelial cells by stabilizing the association of TβRI with caveolin-1 and promoting caveolar localization of TGFβ receptor complexes [40] .
Moreover, Smad7, besides its inhibitory role in TGFβ signaling, functions also as an adaptor protein, facilitating the activation of non-Smad signaling pathways involving TGFβ-associated kinase 1 (TAK1) and the p38 and Jun N-terminal kinase (JNK) MAPK pathways [48] (Fig. 2) . It has been also shown that Smad7 is required for the TGFβ-induced activation of the phosphatidylinositol 3′-kinase (PI3K)-protein kinase B (Akt) pathway [49, 50] . It is not known, however, whether receptor signaling complexes containing Smad7 are located in caveolae in these cases. Taking into account these data and considering that lipid rafts/caveolae function as signaling centers for receptor tyrosine kinases [51] , it seems possible that location of the TGFβ receptors to clathrin-coated pits or caveolae may influence the balance between Smad-dependent and non-Smad TGFβ signaling pathways [52, 53] .
Endocytosis of TGFβ Receptors
Internalization Both type I and type II TGFβ receptors constantly undergo rapid internalization in the absence and presence of ligand binding [20, 21, 30, 31, [54] [55] [56] [57] . It has been shown that activated TGFβ receptors are internalized from plasma membrane via at least two different routes, i.e. clathrin-and caveolin-dependent endocytosis [22, 58, 59] . The localization of the receptor complexes in the plasma membrane microdomains, clathrin-coated pits or caveolae, predetermines the route they will follow (Fig. 1) .
Clathrin-dependent internalization of the activated receptor complex is mediated by the clathrin coat adaptor complex AP2 [28] . Both TβRI and TβRII directly interact with the adaptor protein β2-adaptin which promotes their association with AP2 [60] . TβRIII also has been reported to internalize through clathrin-coated pits due to direct binding to β-arrestin-2 [61] . Phosphorylation of TβRIII on Thr841 by TβRII promotes this association [61] . Overexpression of TβRIII affects intracellular trafficking of TβRII by recruiting TβRII to EEA1-and Rab5-positive EE [9] . The internalization of the receptors is prevented by dominant negative mutants of dynamin or epidermal growth factor receptor substrate 15 (EPS15), and also by potassium depletion [20, 21] . Depletion of cellular potassium blocks clathrin-mediated endocytosis by preventing assembly of the clathrin lattice [62] , and dominant negative EPS15-DIII binds to AP2, inhibiting the formation of clathrin-coated vesicles [63] . Dominant negative dynamin interferes with both clathrin-dependent and caveolae-dependent internalization [33] .
It has been shown that TGFβ receptors located in lipid rafts are internalized through caveolin-dependent pathways [21, [64] [65] [66] (Fig. 1) . Disruption of cholesterol using methyl-β-cyclodextrin or nystatin shifted receptors into the non-raft compartment and inhibited caveolin-mediated endocytosis [21] . Caveolae at steady state are relatively static structures at the cell surface, but their internalization can be stimulated by various agents, such as SV40 virus, glycosphingolipids, and cholesterol [67, 68] . Despite the different agents used to stimulate caveola internalization, there are common mechanisms involved in these pathways with a crucial role for dynamin, Src kinases, protein kinase C, and actin recruitment [69] . Interfering with these mechanisms could provide more information about the regulation of caveolin-dependent internalization of TGFβ receptors.
Early endosomes
Eventually, any routes of entry merge at the Rab5-and EEA1-marked EE [28, 33] . Accordingly, internalized TGFβ receptors were found to be located in EE for extended periods [9, 20, 21, 35, 56, 66] . Clathrinmediated endocytosis is the fastest internalization pathway [70] . Shortly after fission from the plasma membrane clathrin-coated vesicles are uncoated and, after a series of homotypic fusion events, deliver internalized cargo molecules to EE [70, 71] (Fig. 1) . Formation of the clathrin-coated vesicles, their fusion, and movements along microtubules are controlled by the small GTPase Rab5 [72, 73] . Trafficking of endocytic caveolar carriers is more complex. They can fuse with the caveosome in a Rab5-independent manner, or with the EE in a Rab5-dependent manner, or fuse back to the plasma membrane without the involvement of an intermediate station [69] (Fig. 1) . Thereby, caveolinmediated endocytosis may introduce additional bifurcation points in the routing of the receptors. Caveosomes can also communicate with EE via a pathway regulated by Rab5 [74] . In addition, it has been shown that clathrin-coated vesicles and endocytic caveolar carriers can fuse independently of Rab5 before reaching the EE; these caveolin-1 and clathrin double-positive vesicles then fuse with EE in a Rab5-dependent process [66] . Experimental results suggest that early endosomal trafficking controlled by Rab5 can affect the level of TGFβ signaling [75, 76] . In HepG2 cells, overexpression of RIN1, a Rab5 guanine nucleotide exchange factor, accelerates endocytosis of TGFβ receptors and enhances Smad-mediated TGFβ signaling [75] .
The primary function of the EE is the sorting of internalized cargo to different intracellular destinations, which not always is determined by the mechanism of endocytosis [7, 33, 71, 77] . Individual EE has a complex structure with tubular and vacuolar domains. The limiting membrane contains a mosaic of subdomains that differ in composition, including domains enriched in Rab5, Rab4, Rab11, Arf1/COPI, retromer, and caveolae [78] . These subdomains enable EE to fulfill its variable functions, such as sorting cargo for recycling back to the plasma membrane, degradation in lysosome, sending cargo to the TGN via retrograde traffic, or enhancing signaling transduction [71, 77, 79] (Fig. 1) .
The membrane of EE is enriched in phosphatidylinositol-3′-phosphate (PtdIns3P) [59] and can therefore recruit the FYVE domain-containing proteins Smad anchor for receptor activation (SARA) and endofin [20, [80] [81] [82] . SARA presents Smad2 and Smad3 to TβRI and promotes their phosphorylation [20, 82] (Fig. 2) . In addition, SARA can contribute to TGFβ signaling by slowing down the trafficking of the receptors through EE. It has been shown that SARA overexpression causes endosomal enlargement and significantly delays the recycling of transferrin acting downstream of Rab5-regulated endosomal trafficking [83] . Endofin, in turn, interacts with TβRI and Smad4 and may facilitate the formation of a Smad2/3-Smad4 complex in endosomes by bringing Smad4 to the proximity of the receptor complex [80] (Fig. 2) . Thus, EE could act as an amplifier of TGFβ signaling. These findings led to a model of TGFβ signaling regulation that proposes that Smad-mediated signaling is initiated only in EE, suggesting a critical role for clathrindependent internalization of TGFβ receptors [57] . However, it has been reported that Smad-mediated signaling can also be initiated from the plasma membrane without requirement of endocytosis or SARA [55] . Smads may be presented to the receptors on the plasma membrane by other adaptor proteins (Fig. 2) . For example, Dab2 associates with both the type I and type II TGFβ receptors and TGFβ stimulation triggers a transient increase in association of Dab2 with Smad2 and Smad3 [84] . Moreover, cytoplasmic promyelocytic leukemia (cPML) tumor suppressor protein can mediate formation of a TβRI/II-Smad2/3-SARA complex at the plasma membrane and is required for its movement into the EE [85] .
Post-EE Trafficking of TGFβ Receptors

Recycling
As mentioned above, in EE internalized TGFβ receptors are sorted for degradation or for recycling to the cell surface (Fig. 1) . It has been shown that most of internalized TGFβ receptors are recycled back to the cell surface and can serve again [21, 56] . The recycling proceeds via the perinuclear recycling endosomes and is impaired by dominantnegative Rab11 [56, 86] . In epithelial cells, retromer is required for Rab11-dependent TβRII recycling after internalization to the Rab5-positive EE [87] . TβRII directly binds the retromer Vps26 subunit independently of ligand, and in the absence of retromer TβRII is unable to enter the Rab11-positive compartment and shows diminished recycling [87] . Interaction between TβRII and Rab11 can be mediated also by vasodilator-stimulated phosphoprotein (VASP), which is necessary for the receptor recycling in hepatic stellate cells [88] . Transportation of TβRI to Rab11-positive endosomes is also dependent on retromer. In neurons the retromer is recruited to the receptor by beclin-1, a component of the type III phosphatidylinositol-3-kinase complex [89] . SH2-and SH3-containing adaptor proteins CIN85 and Dab2 promote recycling of TβRI and TβRII, respectively [86, 90] .
Akt-induced phosphorylation of the endosomal membraneassociated Rab-GTPase Akt substrate of 160 kDa (AS160) enhances transportation of the TGFβ receptors from intracellular compartments to the cell surface [91] . AS160 is an active GTPase-activating protein (GAP) for Rab2, Rab8, Rab10, and Rab14 [92] , and phosphorylation by Akt inhibits its GAP activity [93] . Rab2 is required for protein transport from the ER to the Golgi complex [94] ; Rab8 is involved in vesicular traffic between the TGN and the basolateral plasma membrane [95] ; Rab10 regulates ER structure and dynamics [96] ; and Rab14 is involved in the biosynthetic/recycling pathway between the Golgi and endosomal compartments [97] . Because all these Rabs are involved in the regulation of the traffic between ER, Golgi complex and plasma membrane, it is possible that inhibition of AS160 could affect the transport of newly synthesized receptors, or internalized TGFβ receptors that were sent from EE to the TGN via retrograde traffic (Fig. 1) .
As TGFβ activates Akt and induces the expression of CIN85 [49, 50, 86] , these data suggest that recycling of TGFβ receptors can be regulated via a positive feedback loop, where TGFβ stimulation promotes the transport of the TGFβ receptors to the cell surface.
Lysosomes
It has been shown that ubiquitination of TGFβ receptors by Smurf1 and Smurf2 leads to degradation of the receptors in both proteasomes and lysosomes [21, 44, 45] . The mechanisms that provide delivery of ubiquitinated receptors to the proteasomes or lysosomes are unknown. However, in many cases lysosomal sorting of ubiquitinated proteins is promoted by association with endosomal protein complexes containing the hepatocyte-growth-factor-regulated tyrosine kinase substrate (Hrs), which functions in cargo delivery to internal membranes of multivesicular late endosomes via a series of endosomal sorting complexes known as the 'ESCRT' machinery [71, 79] . As it has been shown that Hrs plays both positive and negative roles in TGFβ signaling [22] , it is conceivable that Hrs can direct internalized ubiquitinated TGFβ receptors to the lysosomes (Fig. 1) .
The phosphorylation status of the TGFβ receptors may also be important for their sorting to degradation [98] . The adaptor protein Dapper2 (Dpr2) has a high binding affinity to the activated receptors, and overexpression of Dpr2 leads to lysosomal degradation of cell surface TβRI [99, 100] . As Dpr2 protein is found in late endosomes, it has been proposed that Dpr2 modulates the levels of cell surface TβRI by targeting the endocytosed activated receptors for lysosomal degradation [22] . The Rho-associated serine/threonine kinase Rock2 also binds to activated TβRI and accelerates its lysosomal degradation independently of Dpr2 [101] .
APPL positive endosomes
Full-length TβRI or its intracellular domain (ICD) can be translocated to the nucleus [102, 103] (Fig. 1) . It has been shown that nuclear accumulation of the ICD of TβRI is dependent on APPL proteins [104] . APPL1 and APPL2 bind to the active GTP-bound form of Rab5 and label a population of peripheral endosomes which can mediate signaling between the plasma membrane and the nucleus [105] . Most APPL endosomes are precursors of early EEA1-and PtdIns3P-positive endosomes, and represent an early endocytic intermediate common to a subset of clathrin-derived endocytic vesicles and macropinosomes [106] . The E3 ubiquitin ligase tumor necrosis factor-associated factor 6 (TRAF6) is required for TβRI-APPL complex formation and this interaction is promoted by TGFβ [104] . It is not known whether APPL-positive endosomes can also transport full-length TβRI to the nucleus.
TGFβ Signaling is Controlled by Receptor Trafficking
Both TGFβ and its receptors are ubiquitously expressed, hence, the fine regulation of cellular responses involves several levels of control including the regulation of expression, trafficking, and downregulation of the receptor proteins. To fulfill their signaling role, TGFβ receptors need to be expressed at the plasma membrane of cells. However, only a fraction of the TGFβ receptors appear on the cell surface and are available for TGFβ binding, whereas the majority of the receptors are retained inside the cells [4, 86, 107] . It has been proposed that this intracellular pool of TβRI and TβRII receptors could serve as a repository that enables redistribution of the receptors to the cell surface, conferring steady TGFβ responsiveness [4] . A similar mode of rapid and specific modulation of protein expression on the plasma membrane has been described for the insulin-regulated glucose transporter GLUT4 in fat and muscle cells, and for the cell-cell adhesion protein platelet-endothelial cell adhesion molecule (PECAM) in endothelial cells [108] .
In addition, it should be considered that compartmentalization of the TGFβ receptors could also diversify signal networks by bringing them into contact with specific interaction partners or substrates. For example, TGFβ-induced receptor complexes are still active after internalization and phosphorylate Smads in EE [20, 76] (Fig. 2) . It remains to be explored whether TGFβ receptors on plasma membrane and on EE activate different signaling pathways. The balance between clathrin-dependent endocytosis and caveolar/lipid-raft mediated endocytosis of the receptors is also important for the resulting Smad-mediated TGFβ signaling. A mathematical model developed by Zi and Klipp suggests that if clathrin-dependent internalization is dominant, Smad activation becomes a sustained response. Domination of clathrin-independent endocytosis leads to transient Smad activation [109] . Simulation suggests that changing the balance between the two branches of endocytosis has relatively little effect on the early Smad signal, and has larger effect in reshaping long-term Smad activity [109] . Additionally, in the context of different compartments, receptors may have distinctive functions which are not related to their primary activity. For example, it has been shown that the intracellular domain of TβRI can act as a transcription factor in the nucleus, activating Snail and MMP2 genes [103] (Fig. 2) . In another study, full-length TβRI was also found to be translocated to the nucleus of HER2-transformed MCF10A human breast epithelial cell line where it regulated nuclear RNA processing [102] .
The importance of proper control of TGFβ receptor intracellular trafficking is emphasized by clinical data, as mislocalization of receptors was described in connection with several human diseases. Defective trafficking has been suggested to contribute to reduced TβRII surface expression in mitogen-activated CD4 + T cells from patients with Sézary syndrome [110] . Although the intracellular pool of the receptors in these cells appears normal, they exhibit little to none TβRII at the cell surface following mitogen stimulation [110] . Increased cytoplasmic presence of TβRII in breast cancer tissue was associated with poor prognosis. In the Shanghai Breast Cancer Study, expression of TβRII and p-Smad2 was evaluated in breast tissue of 1045 breast cancer cases [111] . It was found that expression of TβRII predominantly in the cytoplasm correlated with an invasive histological type and with reduced cancer-free survival [111] . In acute promyelocytic leukemia pathogenesis, a PML-RARα leukemogenic fusion protein prevents cPML from participating in the regulation of the TGFβ1 pathway [85] . Neddylation of TβRII by c-Cbl promotes clathrin-mediated receptor endocytosis. A neddylation-activity-defective c-Cbl mutant was identified in leukemia patients, implying a link between aberrant TβRII neddylation and trafficking and leukemia development [27] . An E221V/N238I TβRII mutant found in human oral squamous cell carcinoma showed attenuated endocytosis and enhanced TGFβ signaling [112] . Mutations in the BMPR2 gene that affect the folding and subcellular trafficking of BMPR-II have been shown to be associated with pulmonary arterial hypertension [113, 114] .
It has been suggested that defective trafficking of TGFβ receptors from ER to the plasma membrane could be a mechanism of hereditary hemorrhagic telangiectasia (HHT) in some patients [115] . HHT type 1 and type 2 result from mutations in the genes encoding endoglin, an auxiliary protein for TGFβ binding to signaling TGFβ receptors, and activin-like kinase 1, a type I receptor for TGFβ, BMP-9 and BMP-10, respectively [58] . It has been found that the majority of mutations result in the retention of these proteins in the ER [115, 116] .
Conclusions and Perspectives
The fact that the TGFβ receptors are localized at multiple sites makes the regulation of TGFβ signaling complex. Strict and complicated control systems ensure that the partners are sustained in proper places. Resolving the mechanisms regulating the subcellular localization of TGFβ receptors will provide a better understanding of the regulation of TGFβ signaling in the context of health and disease. Newly synthesized TβRI and TβRII are delivered to the plasma membrane via separate routes, suggesting that a coordinating mechanism ensures simultaneous appearance of both receptors on the cell surface. Such a mechanism, as well as regulation of the recycling of receptors, modulates the sensitivity of cells to TGFβ. In addition, localization of the receptors to different membrane microdomains or to different cellular compartments makes the assembly of different signaling platforms possible. For example, it is becoming increasingly evident that lipid-rafts are required not only to turn off signaling, but also to mediate TGFβ-induced non-Smad signaling. Understanding the roles of different compartments in TGFβ signaling is important for developing methods for selective inhibition of the pro-tumorigenic, but not tumor suppressive, TGFβ activities.
